HEMISPHERIAN
Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.
HEMISPHERIAN
Industry:
Biotechnology Consulting Health Care Health Diagnostics
Founded:
2015-01-01
Address:
Oslo, Oslo, Norway
Country:
Norway
Website Url:
http://www.hemispherian.com
Total Employee:
1+
Status:
Active
Contact:
+47 406 03 455
Email Addresses:
[email protected]
Total Funding:
3.39 M USD
Technology used in webpage:
SPF Google Apps For Business Squarespace Hosted Google DNS Google Domains Google Cloud DNS
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Meneldor
Meneldor investment in Seed Round - Hemispherian
BIF Partners
BIF Partners investment in Convertible Note - Hemispherian
Investinor
Investinor investment in Seed Round - Hemispherian
PAACS Invest AS
PAACS Invest AS investment in Seed Round - Hemispherian
Official Site Inspections
http://www.hemispherian.com Semrush global rank: 5.3 M Semrush visits lastest month: 1.56 K
- Host name: 198.202.211.1
- IP address: 198.202.211.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Hemispherian"
Hemispherian - Crunchbase Company Profile & Funding
Organization. Hemispherian . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Hemispherian is …See details»
Hemispherian - Funding, Financials, Valuation & Investors
Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
About Hemispherian | Leading the Way in Epigenetic …
Learn about Hemispherian's mission, vision, and commitment to advancing epigenetic cancer therapeutics. Meet our expert team and understand our dedication to transforming cancer treatment through innovative research and …See details»
Hemispherian 2025 Company Profile: Valuation, …
Hemispherian General Information Description. Operator of a biotechnology company intended to develop treatments for aggressive types of cancer. The company engages in developing personalized cancer therapies to fight …See details»
Hemispherian - The Org
Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Its mission is to development a new drug to treat Glioblastoma Multiforme.See details»
Hemispherian raises the first tranche of a Series A to fund the ...
Nov 24, 2022 Hemispherian is an innovative pharmaceutical company focused on developing a novel class of small molecule drugs (GLIX). GLIX compounds target the TET2 enzyme and …See details»
Hemispherian Company Profile - Craft
Hemispherian has 5 employees at their 1 location and $9.85 m in total funding,. See insights on Hemispherian including office locations, competitors, revenue, financials, executives, …See details»
Hemispherian - Contacts, Employees, Board Members, Advisors
Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.See details»
Hemispherian | VentureRadar
Hemispherian is an innovative preclinical pharmaceutical company focused on developing a novel class of small molecule drugs. These drugs target the TET2 enzyme as an epigenetic therapy …See details»
Hemispherian AS: Drug pipelines, Patents, Clinical trials - Synapse
Jul 28, 2023 Explore Hemispherian AS with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Nervous System Diseases, Neoplasms, Technology …See details»
Hemispherian's Leadership Team - Team members and org chart
The current leadership team at Hemispherian has a variety of experience in both the public and private sector. They have worked as group leaders, software engineers, and senior managers …See details»
Hemispherian - Norway Health Tech
Hemispherian is an innovative pharmaceutical company focused on developing a novel class of small molecule drugs (GLIX) that target the TET2 enzyme as an epigenetic therapy for …See details»
Hemispherian News | Latest Updates
Hemispherian Secures EUR 10M in Financing from the European Innovation Council (EIC) Accelerator Program. Read More. Hemispherian raises seed funding for novel cancer …See details»
☑️Hemispherian As — Consulting Organization from Norway, …
Hemispherian As — Consulting Organization from Norway with 2-10 employees, has experience with European Commission Directorate-General for International Partnerships (EuropeAid …See details»
Hemispherian raises the first tranche of a Series A to fund the ...
Nov 24, 2022 Hemispherian is Meneldor's sixth and most recent addition to their list of portfolio companies. About Kistefos Kistefos AS is a private investment company owned by Christen …See details»
Hemispherian - Updates, News, Events, Signals & Triggers
Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.See details»
Short introduction to Hemispherian
Sep 10, 2020 Discover Hemispherian, a biopharmaceutical company revolutionizing cancer care through novel epigenetic therapeutics. Home. News. Pipeline. Science. Team. Advisors. …See details»
Hemispherian Company Information - Funding, Investors, and …
The company Hemispherian has raised a total of $4.36m in funding over 2 rounds. Key Insights: Unknown: $3.03m; Seed: $1.33m; 2025. Hemispherian Unknown (2022, $3M) $3.03m. 2025. …See details»
Hemispherian Science | Unraveling the Power of Epigenetics in …
Hemispherian has developed a suite of promising compounds that are highly efficient at enhancing the activity of the TET2 enzyme. These GLIX molecules are highly selective anti …See details»